Micronucleus incidence and their chromosomal origin related to therapy in acute lymphoblastic leukemia (ALL) patients:: Detection by micronucleus and FISH techniques

被引:22
作者
Acar, H
Çaliskan, Ü
Demirel, S
Largaespada, DA
机构
[1] Selcuk Univ, Fac Med, Dept Med Genet, Konya, Turkey
[2] Selcuk Univ, Fac Med, Dept Pediat, Konya, Turkey
[3] Univ Minnesota, Ctr Canc, Dept Genet & Cell Biol & Dev, Minneapolis, MN USA
来源
TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS | 2001年 / 21卷 / 05期
关键词
ALL; antileukemic agents; micronucleus; FISH;
D O I
10.1002/tcm.1022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Micronucleus assay and dual color-fluorescence in situ hybridization (DC-FISH), using centromere-specific and whole chromosome-specific painting probes, are considered a useful screening test to determine the incidence of micronucleus, their origin and contents. The patients with acute lymphoblastic leukemia (ALL), who had undergone chemotherapy, were analysed before and after treatment with vincristine, methotrexate, daunomycin, prednisone, and asparaginase. The incidence of micronuclei after the antileukemic agent treatment was significantly higher than before the treatment. Application of DC-FISH using a combination of whole chromosome-specific painting probes and the same chromosome-specific a-satellite centromeric probe showed that there were no significant differences in the micronucleus incidence for any specific chromosome (chromosomes 7, 8, 11, 17, X, and Y). There were no significant differences between the incidence of centromere-positive micronuclei and the incidence of centromere-negative micronucleus. We concluded that antileukemic agents induced the somatic genetic damage but this damage is not related to any specific chromosome studied. Teratogenesis Carcinog. Mutagen. 21:341-347, 2001. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:341 / 347
页数:7
相关论文
共 24 条
[11]  
HALL S C, 1988, Journal of Radiological Protection, V8, P97, DOI 10.1088/0952-4746/8/2/004
[12]   TUMOR-SUPPRESSOR GENES [J].
HINDS, PW ;
WEINBERG, RA .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1994, 4 (01) :135-141
[13]   MICRONUCLEI IN ERYTHROPOIETIC BONE-MARROW CELLS - RELATION TO CYTOGENETIC PATTERN AND PROGNOSIS IN ACUTE NONLYMPHOCYTIC LEUKEMIA [J].
HOGSTEDT, B ;
NILSSON, PG ;
MITELMAN, F .
CANCER GENETICS AND CYTOGENETICS, 1981, 3 (03) :185-193
[14]  
IHNAT DH, 1983, J RHEUMATOL, V20, P742
[15]   THE INVIVO MICRONUCLEUS ASSAY IN MAMMALIAN BONE-MARROW AND PERIPHERAL-BLOOD - A REPORT OF THE UNITED-STATES-ENVIRONMENTAL-PROTECTION-AGENCY GENE-TOX PROGRAM [J].
MAVOURNIN, KH ;
BLAKEY, DH ;
CIMINO, MC ;
SALAMONE, MF ;
HEDDLE, JA .
MUTATION RESEARCH, 1990, 239 (01) :29-80
[16]   MICRONUCLEI IN LYMPHOCYTES OF YOUNG-PATIENTS UNDER ANTILEUKEMIC THERAPY [J].
MIGLIORE, L ;
GUIDOTTI, P ;
FAVRE, C ;
NARDI, M ;
SESSA, MR ;
BRUNORI, E .
MUTATION RESEARCH, 1991, 263 (04) :243-248
[17]   A breakpoint map of recurrent chromosomal rearrangements in human neoplasia [J].
Mitelman, F ;
Mertens, F ;
Johansson, B .
NATURE GENETICS, 1997, 15 (Suppl 4) :417-474
[18]  
Norrpa H, 1993, ENVIRON HEALTH PER S, V101, P139
[19]  
PELZ L, 1988, HUM GENET, V81, P3840
[20]  
SALAVOTINEK S, 1996, INT J RADIAT BIOL, V70, P393